3
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Kinetics of (-)125Iodocyanopindolol Binding to Intact Human Mononuclear Cells

, , &
Pages 773-785 | Published online: 26 Sep 2008
 

Abstract

In association experiments of (-)125Iodocyanopindolol (125ICYP) with human mononuclear cells (MNC) at 70 pM and a temperature of 37°C equilibrium was reached within 30 min. However, when the same experiments were performed at a concentration of 4 pM 125ICYP, equilibrium was only reached after 3 hours. The consequences of incomplete equilibrium for the interpretation of binding experiments under the incorrect assumption that equilibrium has been reached, was investigated at equilibration times of one, two and three hours. The dissociation constant, Kd, decreased from 7.4 ± 0.2 pM after one hour to 2.5 ± 0.4 pM after three hours of incubation while the receptor density, Ro, decreased from 970 ± 170 to 713 ± 58 sites/cell. Analysis of computer simulated binding curves confirmed the decrease in Kd and Ro at prolonged incubations. We conclude that in 125ICYP binding in intact MNC one hour of incubation is not sufficient to obtain equilibrium at the lower concentrations. This leads to an overestimation of Kd- and to a lesser extent of Ro-values. Extending the incubation time to three hours on the other hand may lead to a loss of cells and therefore to an underestimation of Ro.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.